Innate Pharma S.A. (IPHYF)
OTCMKTS · Delayed Price · Currency is USD
2.060
0.00 (0.00%)
At close: Aug 11, 2025
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $212.58 million as of August 20, 2025. Its market cap has increased by 21.39% in one year.
Market Cap
212.58M
Enterprise Value
154.54M
Revenue
20.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.06
Market Cap Chart
Since November 1, 2006, Innate Pharma's market cap has increased from 1.01M to 212.58M, an increase of 20,910.94%. That is a compound annual growth rate of 32.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2025 | 216.75M | 30.90% |
| Dec 31, 2024 | 165.58M | -29.08% |
| Dec 29, 2023 | 233.49M | -17.19% |
| Dec 30, 2022 | 281.97M | -29.50% |
| Dec 31, 2021 | 399.94M | 19.60% |
| Dec 31, 2020 | 334.40M | -36.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 610.45M |
| Glass House Brands | 554.44M |
| Nika Pharmaceuticals | 453.04M |
| CytoDyn | 363.56M |
| Northwest Biotherapeutics | 355.76M |
| American Oncology Network | 355.44M |